Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 6, 2013 PRIMARY DOCUMENT
10-Q May 15, 2013 FORM 10-Q
4 May 9, 2013 PRIMARY DOCUMENT
4 May 9, 2013 PRIMARY DOCUMENT
4 May 9, 2013 PRIMARY DOCUMENT
8-K May 9, 2013 8-K
EFFECT Apr 23, 2013
CORRESP Apr 22, 2013
424B3 Apr 19, 2013 424B3
S-1/A Apr 17, 2013 AMENDMENT TO FORM S-1
EFFECT Apr 16, 2013
DEF 14A Apr 15, 2013 SCHEDULE 14A
D Apr 11, 2013
S-1 Apr 5, 2013 FORM S-1
10-K Mar 28, 2013 ANNUAL REPORT
4 Mar 13, 2013 PRIMARY DOCUMENT
4 Mar 13, 2013 PRIMARY DOCUMENT
8-K Mar 13, 2013 8-K
8-K Feb 28, 2013 8-K
8-K Feb 25, 2013 CURRENT REPORT
UPLOAD Feb 21, 2013
S-1/A Feb 6, 2013 S-1/A
CORRESP Feb 5, 2013
UPLOAD Jan 30, 2013
S-1 Jan 28, 2013 FORM S-1
← Newer Page 23 of 26 · 643 filings Older →